RBMY1E
geneOn this page
Summary
RBMY1E (RNA binding motif protein Y-linked family 1 member E, HGNC:23916) is a protein-coding gene on chromosome Yq11.223, encoding RNA-binding motif protein, Y chromosome, family 1 member E (A6NEQ0). RNA-binding protein which may be involved in spermatogenesis.
This gene encodes a protein containing an RNA-binding motif in the N-terminus and four SRGY (serine, arginine, glycine, tyrosine) boxes in the C-terminus. Multiple copies of this gene are found in the AZFb azoospermia factor region of chromosome Y and the encoded protein is thought to be involved in spermatogenesis. Most copies of this locus are pseudogenes, although six highly similar copies have full-length ORFs and are considered functional. Four functional copies of this gene are found within inverted repeat IR2; two functional copies of this gene are found in palindrome P3, along with two copies of PTPN13-like, Y-linked.
Source: NCBI Gene 378950 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 1 total — 1 pathogenic
- MANE Select transcript:
NM_001006118
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23916 |
| Approved symbol | RBMY1E |
| Name | RNA binding motif protein Y-linked family 1 member E |
| Location | Yq11.223 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000242389 |
| Ensembl biotype | protein_coding |
| Entrez | 378950 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 nonsense_mediated_decay
ENST00000358944, ENST00000382658, ENST00000382659
RefSeq mRNA: 1 — MANE Select: NM_001006118
NM_001006118
CCDS: CCDS35481
Canonical transcript exons
ENST00000382659 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001619375 | 21912169 | 21912346 |
| ENSE00001635505 | 21915946 | 21916058 |
| ENSE00001802644 | 21915366 | 21915469 |
| ENSE00003468556 | 21910101 | 21910253 |
| ENSE00003480174 | 21906910 | 21907020 |
| ENSE00003482521 | 21905813 | 21905923 |
| ENSE00003528506 | 21907976 | 21908090 |
| ENSE00003547647 | 21904606 | 21904694 |
| ENSE00003559850 | 21904781 | 21904891 |
| ENSE00003577506 | 21906358 | 21906468 |
| ENSE00003613569 | 21903622 | 21904194 |
| ENSE00003721712 | 21917920 | 21918032 |
Expression profiles
Bgee: expression breadth tissue_specific, 8 present calls, max score 83.65.
Top tissues by expression
131 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.65 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.09 | gold quality |
| right testis | UBERON:0004534 | 62.28 | gold quality |
| testis | UBERON:0000473 | 59.14 | gold quality |
| left testis | UBERON:0004533 | 57.74 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| liver | UBERON:0002107 | 28.27 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.88 | gold quality |
| blood | UBERON:0000178 | 26.62 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| muscle of leg | UBERON:0001383 | 25.21 | silver quality |
| leukocyte | CL:0000738 | 24.80 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.23 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
23 targeting RBMY1E, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
| HSA-MIR-11181-3P | 99.75 | 66.38 | 2205 |
| HSA-MIR-766-5P | 99.47 | 67.91 | 2225 |
| HSA-MIR-4777-3P | 99.15 | 68.92 | 626 |
| HSA-MIR-1843 | 98.97 | 66.07 | 838 |
| HSA-MIR-4802-5P | 98.97 | 66.26 | 833 |
| HSA-MIR-6894-5P | 98.70 | 63.78 | 809 |
| HSA-MIR-6831-5P | 98.26 | 67.20 | 990 |
| HSA-MIR-509-3P | 98.12 | 67.25 | 612 |
| HSA-MIR-3927-3P | 97.68 | 66.76 | 892 |
| HSA-MIR-7154-3P | 97.65 | 65.02 | 985 |
| HSA-MIR-490-5P | 96.75 | 65.81 | 661 |
| HSA-MIR-875-5P | 96.74 | 66.48 | 579 |
Cross-species orthologs
11 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Rbmyf3 | ENSMUSG00000091987 |
| mus_musculus | Rbmyf5 | ENSMUSG00000093918 |
| mus_musculus | Rbmyf7 | ENSMUSG00000093987 |
| mus_musculus | Rbmyf6 | ENSMUSG00000094511 |
| mus_musculus | Rbmy | ENSMUSG00000094658 |
| mus_musculus | Rbmyf2 | ENSMUSG00000095852 |
| mus_musculus | Rbmyf8 | ENSMUSG00000095948 |
| mus_musculus | Rbmyf9 | ENSMUSG00000096520 |
| mus_musculus | Rbmyf4 | ENSMUSG00000101667 |
| mus_musculus | Rbmyf1 | ENSMUSG00000102053 |
| rattus_norvegicus | Rbmy1j | ENSRNOG00000060963 |
Paralogs (36): DAZAP1 (ENSG00000071626), CIRBP (ENSG00000099622), RBM23 (ENSG00000100461), RBM3 (ENSG00000102317), NCL (ENSG00000115053), TIA1 (ENSG00000116001), HNRNPA2B1 (ENSG00000122566), RBM19 (ENSG00000122965), RBM39 (ENSG00000131051), MSI1 (ENSG00000135097), HNRNPA1 (ENSG00000135486), HNRNPD (ENSG00000138668), HNRNPA1L2 (ENSG00000139675), RBMX (ENSG00000147274), A1CF (ENSG00000148584), TIAL1 (ENSG00000151923), RBM46 (ENSG00000151962), HNRNPDL (ENSG00000152795), MSI2 (ENSG00000153944), RBM47 (ENSG00000163694), RBMY1F (ENSG00000169800), HNRNPA3 (ENSG00000170144), RBMXL2 (ENSG00000170748), RBM4B (ENSG00000173914), RBM4 (ENSG00000173933), RBMXL3 (ENSG00000175718), HNRNPA0 (ENSG00000177733), TRNAU1AP (ENSG00000180098), HNRNPAB (ENSG00000197451), RBMXL1 (ENSG00000213516), HNRNPA1L3 (ENSG00000224578), RBMY1J (ENSG00000226941), RBMY1A1 (ENSG00000234414), RBMY1B (ENSG00000242875), RBMY1D (ENSG00000244395), DND1 (ENSG00000256453)
Protein
Protein identifiers
RNA-binding motif protein, Y chromosome, family 1 member E — A6NEQ0 (reviewed: A6NEQ0)
All UniProt accessions (3): A6NEQ0, F2Z2U1, J3KPK3
UniProt curated annotations — full annotation on UniProt →
Function. RNA-binding protein which may be involved in spermatogenesis. Required for sperm development, possibly by participating in pre-mRNA splicing in the testis.
Subunit / interactions. Interacts with splicing factor proteins SFRS3/SRP20, TRA2B/SFRS10, KHDRBS1/SAM68 and KHDRBS3.
Subcellular location. Nucleus.
Tissue specificity. Testis-specific.
Miscellaneous. The RBMY1 proteins are encoded by repeated regions of the Y chromosome, mostly within the AZFb region. The exact number of functional copies is unclear and may vary between individuals, and some of them may represent pseudogenes. The proteins are very similar, which makes the characterization of each protein difficult. Thus, most experiments do not discriminate between the different members. One can therefore suppose that reported interactions with a RBMY1 protein involve all the proteins.
RefSeq proteins (1): NP_001006118* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000504 | RRM_dom | Domain |
| IPR012604 | RBM1CTR | Domain |
| IPR012677 | Nucleotide-bd_a/b_plait_sf | Homologous_superfamily |
| IPR035979 | RBD_domain_sf | Homologous_superfamily |
| IPR050441 | RBM | Family |
Pfam: PF00076, PF08081
UniProt features (13 total): compositionally biased region 9, region of interest 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NEQ0-F1 | 50.09 | 0.08 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 17 (showing top):
GOBP_RNA_SPLICING, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOCC_SPLICEOSOMAL_COMPLEX, GOCC_RIBONUCLEOPROTEIN_COMPLEX, GOMF_MRNA_BINDING, chrYq11, GOBP_MRNA_PROCESSING, MIR7856_5P, MIR766_5P, MIR1843, MIR4802_5P, MIR509_3P, GOCC_NUCLEAR_PROTEIN_CONTAINING_COMPLEX, FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN, GOBP_MRNA_METABOLIC_PROCESS
GO Biological Process (3): mRNA processing (GO:0006397), RNA splicing (GO:0008380), positive regulation of mRNA splicing, via spliceosome (GO:0048026)
GO Molecular Function (3): RNA binding (GO:0003723), nucleic acid binding (GO:0003676), protein binding (GO:0005515)
GO Cellular Component (4): nucleoplasm (GO:0005654), spliceosomal complex (GO:0005681), nucleolus (GO:0005730), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA processing | 2 |
| binding | 2 |
| nuclear lumen | 2 |
| mRNA metabolic process | 1 |
| mRNA splicing, via spliceosome | 1 |
| positive regulation of RNA splicing | 1 |
| regulation of mRNA splicing, via spliceosome | 1 |
| positive regulation of mRNA processing | 1 |
| nucleic acid binding | 1 |
| cellular anatomical structure | 1 |
| nuclear protein-containing complex | 1 |
| ribonucleoprotein complex | 1 |
| intracellular membraneless organelle | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1180 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RBMY1E | A6NGL4 | A6NGL4 | 717 |
| RBMY1E | A6NEC3 | A6NEC3 | 584 |
| RBMY1E | A6NGT6 | A6NGT6 | 577 |
| RBMY1E | RPS4Y2 | Q8TD47 | 501 |
| RBMY1E | AMELY | Q99218 | 447 |
| RBMY1E | RC3H2 | Q9HBD1 | 394 |
| RBMY1E | EIF1AY | O14602 | 389 |
| RBMY1E | RPS4Y1 | P22090 | 371 |
| RBMY1E | SPRY3 | O43610 | 371 |
| RBMY1E | TSPY1 | P09002 | 350 |
| RBMY1E | ZFY | P08048 | 347 |
| RBMY1E | NLGN4Y | Q8NFZ3 | 315 |
| RBMY1E | UTY | O14607 | 307 |
| RBMY1E | RC3H1 | Q5TC82 | 302 |
| RBMY1E | ZFX | P17010 | 294 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RBMY1E | RBMX | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBMY1E | RBMY1F | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBMY1E | RBMX | psi-mi:“MI:0915”(physical association) | 0.000 |
| RBMY1E | RBMY1F | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (3): RBMY1E (Two-hybrid), RBMY1E (Two-hybrid), RBMY1E (Two-hybrid)
ESM2 similar proteins: A0A1I8MUL8, A1YFA7, A2T806, A6NDE4, A6NEQ0, E9Q5K9, E9Q784, F4JCU0, O22703, O23372, O35698, O60828, O74418, O75526, P0C7P1, P0DJD3, P0DJD4, P11596, P78332, Q10B98, Q15415, Q1ECZ9, Q23935, Q24669, Q24761, Q2HJC9, Q3MHY8, Q3UC65, Q3URU2, Q3V0C1, Q4PB36, Q4R626, Q4R813, Q4R881, Q5R840, Q5T200, Q5U2S0, Q60990, Q62504, Q80Y39
Diamond homologs: A0A0A0LLY1, A2A5N3, A2VDB3, A5A6M3, A6NDE4, A6NEQ0, D4AE41, F1QB54, F4I3B3, O60176, O64380, O75526, O93235, P0C7P1, P0C8Z4, P0CB38, P0CP46, P0CP47, P0DJD3, P0DJD4, P10979, P11940, P20965, P21187, P29341, P31483, P32588, P38159, P38760, P39684, P49310, P49311, P52912, P60824, P60825, P60826, P61286, P70318, P84586, Q00539
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 870515 | GRCh37/hg19 Yq11.223-11.23(chrY:23887108-28799937)x0 | Pathogenic |
SpliceAI
1458 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| Y:21904599:CCCTT:C | donor_loss | 1.0000 |
| Y:21904600:CCTTA:C | donor_loss | 1.0000 |
| Y:21904601:CTTA:C | donor_loss | 1.0000 |
| Y:21904602:TTA:T | donor_loss | 1.0000 |
| Y:21904603:T:TG | donor_loss | 1.0000 |
| Y:21904604:A:AC | donor_gain | 1.0000 |
| Y:21904604:A:AT | donor_loss | 1.0000 |
| Y:21904605:C:CC | donor_gain | 1.0000 |
| Y:21904690:GATAA:G | acceptor_gain | 1.0000 |
| Y:21904691:ATAA:A | acceptor_gain | 1.0000 |
| Y:21904692:TAA:T | acceptor_gain | 1.0000 |
| Y:21904693:AA:A | acceptor_gain | 1.0000 |
| Y:21904693:AACT:A | acceptor_loss | 1.0000 |
| Y:21904694:ACTA:A | acceptor_loss | 1.0000 |
| Y:21904695:C:CC | acceptor_gain | 1.0000 |
| Y:21904695:CT:C | acceptor_loss | 1.0000 |
| Y:21904700:T:C | acceptor_gain | 1.0000 |
| Y:21904700:T:TC | acceptor_gain | 1.0000 |
| Y:21904783:ATAT:A | donor_gain | 1.0000 |
| Y:21905809:GTACC:G | donor_loss | 1.0000 |
| Y:21905810:TACCT:T | donor_loss | 1.0000 |
| Y:21905815:ATAT:A | donor_gain | 1.0000 |
| Y:21905921:TTT:T | acceptor_gain | 1.0000 |
| Y:21905921:TTTC:T | acceptor_loss | 1.0000 |
| Y:21905922:TT:T | acceptor_gain | 1.0000 |
| Y:21905923:TCTG:T | acceptor_loss | 1.0000 |
| Y:21905924:C:CC | acceptor_gain | 1.0000 |
| Y:21905928:A:AC | acceptor_gain | 1.0000 |
| Y:21905928:A:C | acceptor_gain | 1.0000 |
| Y:21905931:C:CT | acceptor_gain | 1.0000 |
AlphaMissense
3226 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| Y:21915423:A:C | F52L | 1.000 |
| Y:21915423:A:T | F52L | 1.000 |
| Y:21915425:A:G | F52L | 1.000 |
| Y:21915429:A:C | F50L | 1.000 |
| Y:21915429:A:T | F50L | 1.000 |
| Y:21915431:A:G | F50L | 1.000 |
| Y:21916022:G:C | F11L | 1.000 |
| Y:21916022:G:T | F11L | 1.000 |
| Y:21916024:A:G | F11L | 1.000 |
| Y:21915414:A:C | F55L | 0.999 |
| Y:21915414:A:T | F55L | 0.999 |
| Y:21915416:A:G | F55L | 0.999 |
| Y:21915424:A:G | F52S | 0.999 |
| Y:21915430:A:G | F50S | 0.999 |
| Y:21915435:T:A | R48S | 0.999 |
| Y:21915435:T:G | R48S | 0.999 |
| Y:21915971:A:C | F28L | 0.999 |
| Y:21915971:A:T | F28L | 0.999 |
| Y:21915973:A:G | F28L | 0.999 |
| Y:21916023:A:G | F11S | 0.999 |
| Y:21915436:C:G | R48T | 0.998 |
| Y:21915984:A:T | L24H | 0.998 |
| Y:21916020:A:T | I12N | 0.998 |
| Y:21916023:A:C | F11C | 0.998 |
| Y:21915415:A:G | F55S | 0.997 |
| Y:21915421:A:T | I53N | 0.997 |
| Y:21915427:G:T | A51E | 0.997 |
| Y:21915972:A:G | F28S | 0.997 |
| Y:21916026:A:G | L10P | 0.997 |
| Y:21915424:A:C | F52C | 0.996 |
dbSNP variants (sampled 113 via entrez): RS1160419817 (Y:21904100 G>A), RS1164519279 (Y:21906357 C>T), RS1175616459 (Y:21906334 C>T), RS1180219298 (Y:21904702 GA>G), RS1189660077 (Y:21906342 G>C), RS1194098937 (Y:21904019 A>C), RS1197406025 (Y:21906451 C>T), RS1202321544 (Y:21906473 A>G), RS1214396324 (Y:21903975 C>T), RS1233316015 (Y:21906401 A>T), RS1233391775 (Y:21904737 A>G), RS1240013790 (Y:21903984 C>T), RS1272169212 (Y:21906416 G>A), RS1273430528 (Y:21906454 G>C), RS1280668224 (Y:21904188 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (1): male infertility (MONDO:0005372)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| D007248 | Infertility, Male | C12.100.500.430; C12.100.750.700; C12.200.294.430 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
1 total (human), top 1 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Temozolomide | increases expression | 1 |
Clinical trials (associated diseases)
125 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT02202382 | PHASE4 | COMPLETED | Effects of Korean Red Ginseng on Male Infertility |
| NCT02204826 | PHASE4 | COMPLETED | Effects of Korean Red Ginseng on Semen Parameters in Male Infertility Patients: a Randomized, Placebo-controlled, Double-blind Clinical Study |
| NCT03802864 | PHASE4 | COMPLETED | Post-operative Pain Control of Testicular Sperm Extraction Using Liposomal Bupivacaine |
| NCT06100432 | PHASE4 | ACTIVE_NOT_RECRUITING | Effect of Eurycoma Longifolia (DLBS5055) and Multivitamins (Vitamin C+Vitamin E+ β-carotene) for Infertile Males |
| NCT07523022 | PHASE4 | ENROLLING_BY_INVITATION | Comparison of the Effect of Gonadotropin and Clomiphene Citrate Treatment on Sperm Parameters and the Outcome of Assisted Reproductive Procedures in Subfertile Men Based on the APHRODITE Groups |
| NCT00975117 | PHASE3 | COMPLETED | Spermotrend in the Treatment of Male Infertility |
| NCT01407432 | PHASE3 | COMPLETED | Impact of Folates in the Care of the Male Infertility |
| NCT01895816 | PHASE3 | COMPLETED | Herbal Tonic Fertile Supplement(ZO2C5) |
| NCT02605070 | PHASE3 | TERMINATED | Pilot Study on the Effects of FSH Treatment on the Epigenetic Characteristics of Spermatozoa in Infertile Patients With Severe Oligozoospermia |
| NCT07402759 | PHASE3 | ACTIVE_NOT_RECRUITING | Impact of tdrd9 Gene Mutations in the Therapeutic Response to L-carnitine in Oligoasthenozoospermic Men |
| NCT01880086 | PHASE2 | COMPLETED | Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration |
| NCT02061384 | PHASE2 | COMPLETED | RA-2 13-cis Retinoic Acid (Isotretinoin) |
| NCT02421887 | PHASE2 | COMPLETED | Males, Antioxidants, and Infertility Trial |
| NCT05200663 | PHASE2 | UNKNOWN | Efficacy Comparison of Tamoxifen and Tamoxifen With Antioxidants on Semen Quality of Male With Idiopathic Infertility |
| NCT05290558 | PHASE2 | ACTIVE_NOT_RECRUITING | The Therapeutic Effects of Bu Shen Yi Jing Pill on Semen Quality in Sub Fertile Males: a Randomized Controlled Trial |
| NCT06091969 | PHASE2 | NOT_YET_RECRUITING | Supplementation for Male Subfertility |
| NCT01595308 | PHASE1 | COMPLETED | A Pilot Study to Evaluate the Effect of Pomegranate Juice on Semen Parameters in Healthy Male Volunteers |
| NCT02122211 | PHASE1 | COMPLETED | Choline Dehydrogenase and Sperm Function: Effects of Betaine |
| NCT02575924 | PHASE1 | UNKNOWN | Influence of Culture Media on Clinical Outcomes in Poor Responders or Severe Male Infertility |
| NCT01304927 | PHASE2/PHASE3 | COMPLETED | Vitamin D Supplementation and Male Infertility: The CBG-study a Randomized Clinical Trial |
| NCT02349945 | PHASE2/PHASE3 | COMPLETED | FSH Receptor Polymorphism p.N680S and Efficacy of FSH Therapy |
| NCT05222841 | PHASE2/PHASE3 | COMPLETED | The Effectiveness of Spermotrend Food Supplement in the Treatment of Male Infertility |
| NCT05616598 | PHASE2/PHASE3 | COMPLETED | Effect of New Oral Treatment for Hepatitis C Virus on Seminal Parameters |
| NCT02025270 | PHASE1/PHASE2 | COMPLETED | MSCs For Treatment of Azoospermic Patients |
| NCT04541459 | EARLY_PHASE1 | UNKNOWN | Validation of New Devices Against Ambient Electromagnetic Radiation |
| NCT05792813 | EARLY_PHASE1 | UNKNOWN | Efficacy and Safety of Linggui Yangyuan Paste in Patients With Male Infertility |
| NCT06188936 | EARLY_PHASE1 | COMPLETED | Home Semen Analysis Tests As a Screening Tool for Fertility Patients |
| NCT00012480 | Not specified | COMPLETED | Effect of Environmental Exposures on the Egg Fertilizing Ability of Human Sperm |
| NCT00044369 | Not specified | COMPLETED | Role of the Toxic Metal Cadmium in the Mechanism Producing Infertility With a Varicocele |
| NCT00119925 | Not specified | UNKNOWN | ‘SPRING’-Study: Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists |
| NCT00178516 | Not specified | COMPLETED | Vitamin E and Male Infertility |
| NCT00315029 | Not specified | COMPLETED | Patient-Centered Implementation Trial for Single Embryo Transfer |
| NCT00341120 | Not specified | COMPLETED | Genetic Causes of Male Infertility |
| NCT00481403 | Not specified | COMPLETED | Study of Sperm Molecular Factors Implicated in Male Fertility |
| NCT00548977 | Not specified | COMPLETED | Genetic Studies Spermatogenic Failure |
| NCT00596739 | Not specified | COMPLETED | A Study of the Pre- and Post-operative Semen Analyses and Reproductive Hormone Levels of Men Undergoing Weight-reduction Surgery |
| NCT00756561 | Not specified | COMPLETED | HOP-2A - Intratesticular Hormone Levels |
| NCT00961558 | Not specified | TERMINATED | Canadian Varicocelectomy Initiative (CVI): Effects on Male Fertility and Testicular Function of Varicocelectomy |
| NCT01075334 | Not specified | UNKNOWN | Is a Carnitine Based Food Supplement (PorimoreTM) for Infertile Men Superior to Folate and Zinc With Regard to Pregnancy Rates in Intrauterine Insemination Cycles? |
| NCT01178463 | Not specified | UNKNOWN | Spermatogonial Stem Cells in Azoospermic Patients: a Comparison Between Obstructive and Non-obstructive Azoospermia |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): male infertility